Iniparib (Standard)
Iniparib (Standard) is the analytical standard of Iniparib. This product is intended for research and analytical applications. Iniparib (BSI-201) is an irreversible inhibitor of PARP1, used in the research of triple negative breast cancer.
Product Specifications
CAS Number
160003-66-7
UNSPSC
12352100
Target
Influenza Virus; PARP; Reference Standards
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; Epigenetics; Others
Field of Research
Cancer
Smiles
O=C(C1=CC=C(C([N+]([O-])=O)=C1)I)N
Molecular Formula
C7H5IN2O3
Molecular Weight
292.03
References & Citations
[1]Liu X, et al. Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor. Clin Cancer Res. 2012 Jan 15;18 (2) :510-23.|[2]Yin S, et al. Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. PLoS One. 2017 Aug 17;12 (8) :e0183578.|[3]Ma W, et al. Differential effects of poly (ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein-Barr virus. Proc Natl Acad Sci U S A. 2012 Apr 24;109 (17) :6590-5.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4732008 1.0 µg DNA
Osbpl3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details K0738104 1.0 µg DNA
FAM96A sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 